Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
about
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsDown-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopeniaCharacterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli.Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.Shiga toxin pathogenesis: kidney complications and renal failure.Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitroA prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.Thrombotic microangiopathic syndromes after bone marrow transplantation.Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7.The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharidesShiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinasesComparison of the relative toxicities of Shiga-like toxins type I and type II for micePas, a novel protein required for protein secretion and attaching and effacing activities of enterohemorrhagic Escherichia coli.Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigsResponses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.Enhanced macrophage resistance to Pseudomonas exotoxin A is correlated with decreased expression of the low-density lipoprotein receptor-related protein.Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice.Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response.Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.Therapy and prophylaxis of inhaled biological toxins.Different types of cell death induced by enterotoxins.Persistence of local cytokine production in shigellosis in acute and convalescent stages.Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infectionDifferentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.Interaction of verotoxin 2e with pig intestine.Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2.High diversity of viable bacteria isolated from lymph nodes of slaughter pigs and its possible impacts for food safety.Hantaan virus infection of human endothelial cells
P2860
Q24550740-CD376B62-49FC-458D-87EB-D79F797A8D1EQ28390993-DB11F205-7191-49FF-926E-62631DCC0D59Q33328717-6E5FBDA2-A177-49A5-AF04-2FDE8E9A7AFBQ33328949-1F1EC353-B30C-49B4-867D-77B04C85C3ADQ33331011-AC728383-57E6-4ADB-9607-4072FCF94F8CQ33338331-EFB53D71-C5D1-4EC5-B091-9087E49F1922Q33363208-6FDC5764-22C5-4FF8-A334-B0D452D52ABAQ33364401-AAE904D7-7BEC-4C28-AE47-7085FAC0A1E4Q33376042-32A10B05-1881-4180-A883-EBD13D8D4C1DQ33397541-9956AE8D-F86C-426D-B72A-A4386466F094Q33489940-A0DEB7F3-5770-4D36-9381-7F418224C3D6Q33493023-230BF03B-D76A-4EDC-8D13-F01B5E10AB0FQ33493841-D68D3705-BE6B-461C-AD50-6FC37F8FA9F6Q33494314-4AE7A0EC-F6C5-4FA8-8138-BDB5B3389C35Q33495436-542CC08D-FEA1-48BC-A5A4-901014391626Q33497693-B6B9DC6B-8F53-4836-B5F6-A933E483506FQ33504952-43FEA170-C927-4431-A27A-20A2EEC83A19Q33557728-F8F76054-FE6C-4B34-B212-DACD45D7F0CAQ33599604-CD18121F-A9BB-4A0C-861C-EAA1F48A0F62Q33605233-619A8C27-51F8-4300-913B-A92211A298B7Q33736386-F3F98636-5C82-43B8-9FE9-5B1FD537EFF7Q33923342-2E313EB9-EB42-49EA-B586-D30DE54270A4Q34000714-D50FFCB6-67F2-4688-9411-A25C6FFF7000Q34002432-CD293D5F-F4B3-4609-98B0-A408481151F9Q34003505-1523DCDA-BFB3-4253-BC8D-CEBA566E5FEAQ34004015-A291B00F-5807-479C-8A77-86E2D803453BQ34142282-2D97F0CC-E124-4201-A264-FDE8786367ADQ34409399-64D9B9A6-08E4-425E-934B-81AA67552F5AQ34545284-4A12F266-8763-4ED2-9ED2-BA5574AE4597Q34938668-94B0342F-F364-4877-A588-E6AA13AD3D4BQ35132357-B2AE41B4-3ACE-4898-AA22-0806244A2EC1Q35148875-6A1DBF72-D174-4833-875D-4A61211B1868Q35155921-D1191688-ABCC-4A81-B3C2-5AEBFA62E65EQ35380946-BCFABE8A-F55A-4DBE-921F-7806D9ABC5CAQ35430354-7559D8D8-6EBA-481B-86ED-CA62C291714EQ35480200-4EE71747-0B98-4212-8B91-BB75D164315CQ35490172-388BB833-FB8C-4AB0-8932-120BE02604DFQ35531436-5E9213D5-DCDD-40D1-A50A-08D6D1E78C0DQ35748460-1273E71E-5CF5-4F4B-BDE0-23D85E74C952Q36702197-3A982DE8-DE05-42AE-9FAC-84952BE9C212
P2860
Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Evaluation of the role of Shig ...... an vascular endothelial cells.
@en
Evaluation of the role of Shig ...... an vascular endothelial cells.
@nl
type
label
Evaluation of the role of Shig ...... an vascular endothelial cells.
@en
Evaluation of the role of Shig ...... an vascular endothelial cells.
@nl
prefLabel
Evaluation of the role of Shig ...... an vascular endothelial cells.
@en
Evaluation of the role of Shig ...... an vascular endothelial cells.
@nl
P2093
P356
P1476
Evaluation of the role of Shig ...... an vascular endothelial cells.
@en
P2093
P304
P356
10.1093/INFDIS/164.2.344
P407
P577
1991-08-01T00:00:00Z